E. Matilda Goldberg
Papers
1
Total Citations
67
H-Index
1
About
E. Matilda Goldberg is a pioneer in the development of high-throughput screening technologies for drug discovery. Her primary research focuses on assay miniaturization and automation, particularly through the creation of homogeneous, cell- and bead-based assays that enable rapid, cost-effective analysis of biological interactions. Her most-cited work, "Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology" (1999), has garnered 67 citations and introduced a transformative approach to reducing reagent volumes while maintaining sensitivity. This innovation significantly accelerated the pace of pharmaceutical screening, allowing researchers to test thousands of compounds simultaneously with minimal sample consumption. Goldberg’s contributions have been instrumental in bridging the gap between academic research and industrial-scale drug development, earning her recognition as a leader in assay technology. Her work continues to influence modern screening platforms, making her a key figure for students and researchers interested in the intersection of biochemistry, engineering, and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1